Corvus Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2017 to 2023.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $473K, a 3.05% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.88M, a 5.98% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.84M, a 8.5% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.7M, a 3.04% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.65M, a 9.23% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.84M +$144K +8.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.7M +$50K +3.04% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $1.65M +$139K +9.23% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $1.51M +$57K +3.93% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $1.45M +$60K +4.32% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $1.39M -$9K -0.64% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $1.4M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.